Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial
- Status
- TERMINATED
- Phase
- PHASE3
Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)
- Status
- COMPLETED
- Phase
- PHASE1
Mix Vaccine for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
- Status
- UNKNOWN
- Phase
- N/A
Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
- Status
- WITHDRAWN
- Phase
- PHASE2
Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2